The Team

Hugo Gutiérrez de Terán

Co-Founder & CEO

Senior Lecturer in Computational Biochemistry. Positions at Santiago de Compostela University Hospital, Scripps Research Institute and Uppsala University.

Willem Jespers

Co-founder & CSO

Assistant Professor in AI & Structure-Based Drug Discovery at Leiden University. PhD at Uppsala University. Industry experience at Galapagos.

Marc Willuhn

CMO

Organic chemist with >20 years industry experience in senior management roles. Part of several successful new drug applications.

Frank Putman

CFO

Senior Manager at EY. Over 9 years experience in tax, legal, accounting and M&A. LLM from the University of Amsterdam and an MBA from Hult.

Marc Dominguez Juanola

Business Development Intern

MSc in Bioentrepreneurship at Karolinska Institutet. BSc in Biomedicine at University of Barcelona.

Scientific Advisory Board

Gerard van Westen

Professor of AI and Medicinal Chemistry and head of the computational drug discovery group at Leiden University. One of the world’s leading experts on the use of ML and AI in the field of cheminformatics and drug design.

Johan Åqvist

Professor of Theoretical Chemistry and head of the research division for Computational Biology and Bioinformatics at Uppsala University in Sweden. One of the world leading’s experts in molecular simulations and free energy calculations.

Bart Lenselink

Digital Drug Hunter at Galapagos NV and Team Leader Computational Technologies & Datascience with over 5 years experience in industry

Pieter Stouten

Consultant Computational Technologies in Pharma with over 25 years experience in industry with Pfizer, Nerviano and Galapagos.